PASG
Companies
NASDAQ
Passage Bio Inc.
Health Care
$0.33
-$0.24 (-41.80%)
Price Chart
Overview
About PASG
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Cap
$73.0M
Volume
83.6K
Avg. Volume
73.0K
P/E Ratio
-0.6284
Dividend Yield
0.00%
Employees
98.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.69
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PASG shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$73.0M
Volume83.6K
P/E Ratio-0.63
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 13, 2025Related Securities
Pricing info last updated June 26, 2025 (after market close)Other info last updated April 2, 2025